Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
for Alzheimer Disease
39 locations incl. Phoenix
Sponsor: Lighthouse Pharmaceuticals, Inc.
Sex: All·Age: 55 - 80
Code: NCT06847321·Phase 2·Recruiting·Listed Feb 2025
Accellacare - Sherman Oaks
Clinical research site in Sherman Oaks, California · 4929 VAN NUYS BLVD., SHERMAN OAKS, CA 91403-1702 · (818) 981-7111
As of July 2026, 2 paid clinical trials are recruiting at Accellacare - Sherman Oaks in Sherman Oaks, California. Active studies at this site cover conditions such as Agitation and Alzheimer Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Accellacare - Sherman Oaks (2)
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for Agitation
43 locations incl. Homewood
Sponsor: Celgene
Sex: All·Age: 55 - 90
Code: NCT06808984·Phase 2·Recruiting·Listed Feb 2025
More research sites in Sherman Oaks
- California Neuroscience Research (3 trials)
- CenExel Sherman Oaks CA (California Neuroscience Research) (2 trials)
- Cenexel California Neuroscience Research, LLC (2 trials)
- GSK Investigational Site (2 trials)
- Schuster Medical Research Institute (2 trials)
- Advanced Dermatology and Skin Cancer Institute - Beverly Hills (1 trial)
- Amicis Research Center (1 trial)
- CenExel CNR (1 trial)
- CenExel Sherman Oaks (1 trial)
- Cenexel Cnr - Sherman Oaks (1 trial)
Explore more
Paid clinical trials in Sherman Oaks, CA · California clinical trials